Detalles de la búsqueda
1.
Endocrine therapy in advanced high-grade ovarian cancer: real-life data from a multicenter study and a review of the literature.
Oncologist
; 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38768082
2.
Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer.
Int J Mol Sci
; 25(11)2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38892246
3.
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
N Engl J Med
; 379(5): 417-427, 2018 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29860937
4.
Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO).
Oncologist
; 23(8): 948-955, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29934413
5.
Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.
Lancet Oncol
; 16(7): 787-94, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26028518
6.
Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study.
BJU Int
; 115(1): 65-73, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24180479
7.
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Lancet Oncol
; 15(13): 1442-1450, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25456363
8.
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 14(2): 149-58, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23306100
9.
PD-L1 expression and its prognostic value in metastatic papillary renal cell carcinoma: Results from a GETUG multicenter retrospective cohort.
Eur J Cancer
; 205: 114121, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38749111
10.
Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer.
Pharmaceutics
; 15(2)2023 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36839973
11.
Impact of First Line Antiangiogenic Therapy Duration on Nivolumab Outcome in Metastatic Renal Cell Carcinoma Patients Treated in the GETUG-AFU 26 NIVOREN.
Clin Genitourin Cancer
; 21(6): 643-652, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37635052
12.
Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status.
Eur J Cancer
; 180: 21-29, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36527973
13.
Very Long-Term Complete Remission Can Be Achieved in Men With High-Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial.
Clin Genitourin Cancer
; 21(5): 615.e1-615.e8, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37263910
14.
Impact of Novel Hormonal Agents (Abiraterone, Enzalutamide) on the Development of Visceral and/or Brain Metastases in Patients With Bone-metastatic Castration-resistant Prostate Cancer.
Clin Genitourin Cancer
; 20(5): 495.e1-495.e9, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35562276
15.
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.
Cancer Immunol Immunother
; 60(2): 261-71, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21069322
16.
Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Génitales).
Eur J Cancer
; 158: 1-11, 2021 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34619467
17.
Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?
Eur Urol
; 80(4): 417-424, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34187771
18.
VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinoma.
J Urol
; 184(4): 1273-8, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20723915
19.
Methotrexate-Etoposide-Ifosfamide Compared with Doxorubicin-Cisplatin-Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18-25 Years.
J Adolesc Young Adult Oncol
; 9(2): 172-182, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31702419
20.
Topotecan in combination with radiotherapy in unresectable glioblastoma: a phase 2 study.
J Neurooncol
; 93(2): 253-60, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19139825